Physician

Cyril Ruwende, MB,CHB,DPHIL

According to 2025 Medicare claims, Cyril Ruwende, MB, CHB, DPHIL (NPI: 1376629386) practices interventional cardiology in the Ann Arbor, MI market, with the plurality of this provider's patient population coming from Washtenaw, MI. This provider's primary affiliated billing organization is IHA HEALTH SERVICES ORGANIZATION (NPI: 1487072633; TIN: 383316559) and primary practice location at 48197-1051. Ruwende is affiliated with the McAuley Health Partners ACO, LLC (ACO ID: A4588) and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Ruwende's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 790 traditional Medicare patients, billed 1,376 HCPCS/CPT codes, and received $115,478 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,361 prescription claims across 375 beneficiaries totaling $446,189 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 10 records totaling $257. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $236,018 to $115,478. In contrast, Part D prescription costs have moved sharply higher in recent years, from $39,379 to $446,189. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,646	2,673	$236,018
2016	1,646	2,595	$200,817
2017	1,564	2,810	$197,960
2018	1,672	2,891	$192,869
2019	1,107	2,079	$187,543
2020	580	1,082	$121,549
2021	869	1,662	$163,075
2022	809	1,576	$147,772
2023	798	1,439	$131,040
2024	790	1,376	$115,478

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	218	950	$39,379
2016	196	1,001	$75,015
2017	185	973	$65,486
2018	197	913	$81,413
2019	224	984	$99,521
2020	251	1,239	$148,562
2021	253	1,407	$191,555
2022	304	1,675	$282,314
2023	361	2,064	$398,093
2024	375	2,361	$446,189

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	108	109	$135
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	64	83	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	90	94	$71
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	89	94	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	362	419	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	205	11,848	$216,016
Entresto	Sacubitril/Valsartan	36	2,386	$49,864
Jardiance	Empagliflozin	42	2,520	$47,794
Farxiga	Dapagliflozin Propanediol	35	1,590	$28,753
Repatha Sureclick	Evolocumab	34	1,456	$25,819

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$257	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Cyril Ruwende, MB, CHB, DPHIL?

Tedicare shows public-source Medicare data for Cyril Ruwende, MB, CHB, DPHIL (NPI 1376629386), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Cyril Ruwende, MB, CHB, DPHIL have ACO affiliation data?

Cyril Ruwende, MB, CHB, DPHIL is shown with ACO affiliation data for McAuley Health Partners ACO, LLC (MSSP, ACO ID A4588) and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Cyril Ruwende, MB, CHB, DPHIL?

Cyril Ruwende, MB, CHB, DPHIL is linked to IHA HEALTH SERVICES ORGANIZATION (billing NPI 1487072633) in the available physician profile data.

Does Cyril Ruwende, MB, CHB, DPHIL have Open Payments data?

Cyril Ruwende, MB, CHB, DPHIL has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.